Logo
x

Search

Subscribe Now

Demonstrate

BMS' Deucravacitinib Demonstrate Superiority Over Otezla (apremilast) in P-III POETYK PSO-2 Study for Plaque Psoriasis

BMS' Deucravacitinib Demonstrate Superiority Over Otezla (apremilast) in P-III POETYK PSO-2 Study for Plaque Psoriasis

  • February 3, 2021
Sanofi Reports Results of Dupixent (dupilumab) in P-III LIBERTY ASTHMA VOYAGE Study in Children with Asthma

Sanofi Reports Results of Dupixent (dupilumab) in P-III LIBERTY ASTHMA VOYAGE Study in Children with Asthma

  • October 13, 2020
Lilly and Incyte's Olumiant (baricitinib) Reports Additional Data Demonstrating Reduction in COVID-19 Recovery Time

Lilly and Incyte's Olumiant (baricitinib) Reports Additional Data Demonstrating Reduction in COVID-19 Recovery Time

  • October 9, 2020
Regeneron's REGN-COV2 Demonstrate Reduction in Viral Load and Improve Symptoms in Non-Hospitalized Patients with COVID-19

Regeneron's REGN-COV2 Demonstrate Reduction in Viral Load and Improve Symptoms in Non-Hospitalized Patients with COVID-19

  • September 30, 2020
Eli Lilly's P-tau217 Blood Test Demonstrate High Accuracy in Diagnosis of Alzheimer's Disease

Eli Lilly's P-tau217 Blood Test Demonstrate High Accuracy in Diagnosis of Alzheimer's Disease

  • July 29, 2020
Pfizer and Sangamo's Giroctocogene Fitelparvovec (SB-525) Demonstrate Positive Effect in P-I/II Alta Study for Hemophilia A

Pfizer and Sangamo's Giroctocogene Fitelparvovec (SB-525) Demonstrate Positive Effect in P-I/II Alta Study for Hemophilia A

  • June 19, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.